An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

NCT02173951 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Beta Thalassemia Major

Interventions

DRUG: Deferiprone

Sponsor

Ain Shams University